Literature DB >> 7879633

Changing cognitive functioning in rehabilitation of schizophrenia.

W D Spaulding1, M Sullivan, M Weiler, D Reed, C Richardson, D Storzbach.   

Abstract

A three-factor model is proposed for clinical assessment of cognitive and neuropsychological impairments in schizophrenia. The first factor is stable, pervasive and vulnerability-linked. The second and third include executive, memory and conceptual abilities and are episode-linked. The third factor may be amendable to psychosocial treatment.

Entities:  

Mesh：

Year:  1994        PMID： 7879633     DOI： 10.1111/j.1600-0447.1994.tb05900.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN： 0065-1591


  5 in total

1.  Cognitive remediation of persons with severe and persistent mental illness.

Authors:  J J Cassidy; M Easton; C Capelli; A Singer; A Bilodeau
Journal:  Psychiatr Q       Date:  1996

Review 2.  Psychotherapy for schizophrenia in the year 2030: prognosis and prognostication.

Authors:  William Spaulding; Jeffrey Nolting
Journal:  Schizophr Bull       Date:  2006-08-11       Impact factor: 9.306

3.  Blonanserin ameliorates phencyclidine-induced visual-recognition memory deficits: the complex mechanism of blonanserin action involving D₃-5-HT₂A and D₁-NMDA receptors in the mPFC.

Authors:  Hirotake Hida; Akihiro Mouri; Kentaro Mori; Yurie Matsumoto; Takeshi Seki; Masayuki Taniguchi; Kiyofumi Yamada; Kunihiro Iwamoto; Norio Ozaki; Toshitaka Nabeshima; Yukihiro Noda
Journal:  Neuropsychopharmacology       Date:  2014-08-14       Impact factor: 7.853

Review 4.  Cognitive rehabilitation for people with schizophrenia and related conditions.

Authors:  R L Hayes; J J McGrath
Journal:  Cochrane Database Syst Rev       Date:  2000

5.  High Schizotypal Individuals Are More Creative? The Mediation Roles of Overinclusive Thinking and Cognitive Inhibition.

Authors:  Lixia Wang; Haiying Long; Jonathan A Plucker; Qing Wang; Xiaobo Xu; Weiguo Pang
Journal:  Front Psychol       Date:  2018-09-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.